This inventor holds 1 USPTO granted patent. Top assignee: Keio University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Taisuke Mori: Innovator in Wound Healing Technology
Introduction
Taisuke Mori is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of wound healing through his innovative research and development. His work focuses on creating more effective solutions for accelerating wound healing, which can greatly benefit medical practices.
Latest Patents
Taisuke Mori holds a patent titled "Agent for promoting wound healing comprising platelet-like cell co-expressing platelet surface antigen and mesenchymal cell surface antigen." This invention aims to provide a practical wound healing accelerator that is more effective than traditional methods. The patent describes a platelet-like cell population that co-expresses specific surface markers, allowing for a more efficient healing process. This innovative approach offers a larger quantity of healing agents compared to peripheral blood platelets, resulting in improved wound healing effects.
Career Highlights
Mori is affiliated with Keio University, where he conducts his research and development. His work has garnered attention for its potential to revolutionize wound care and healing practices. With a focus on practical applications, Mori's inventions are paving the way for advancements in medical treatments.
Collaborations
Mori collaborates with esteemed colleagues such as Yumiko Matsubara and Yasuo Ikeda. Their combined expertise contributes to the success of their research initiatives and enhances the impact of their innovations in the medical field.
Conclusion
Taisuke Mori's contributions to wound healing technology exemplify the importance of innovation in medicine. His patented work not only addresses current challenges in wound care but also sets the stage for future advancements. The potential benefits of his inventions could lead to significant improvements in patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
